 Impact of Biodecoding on disability associated with migraineLisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo and Damian Valdés Santiago Multidisciplinar (Montevideo), 2025, vol. 3, 37 Abstract: Introduction: migraine is a common neurological disease. 53% of patients have severe disability.Biodecoding is a holistic method that allows us to know through symptoms what the emotional origin of an illness may be. Methods: an experimental research was designed, pretest-postest and with a control group .40 patients were included in the study,20 who received treatment only with gabapentin (control group) and 20 who were additionally treated with biodecoding (study group). The response was evaluated one month and three months after the intervention. Descriptive statistics and inferences were used to analyze the data. Results: before the intervention, 75% of the patients in both groups had a very severe headache impact. One month after treatment, 70% of the patients in the study group had 15% in the control group had little or no impact. By the third month, 95% of the patients in the study group and 65% of the patients in the control group had little or no impact of the headache. Before treatment, 100% of the patients presented severe disability, after three months this disability had a statistically significant improvement. Conclusions: biodecoding reduces the severe impact of headache and reduces migraine disability Date: 2025 There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:dbk:multid:v:3:y:2025:i::p:37:id:1062486agmu202537 DOI: 10.62486/agmu202537 Access Statistics for this article More articles in Multidisciplinar (Montevideo) from AG Editor |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.